4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-010403
Chief Executive Officer sold 19,952 shares at $125.08 ($2,495,508)
- Chief Executive Officer acquired 19,952 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +19,952 | $26.66 | $531,920 | 838,890 | D |
| 2026-08-12 | Sale : show line 2 in the form 10b5-1 | −19,952 | $125.08 | $2,495,508 | 818,938 | D |
| Open-market sales · 19,952 sh · avg $125.08 · $2,495,508 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-12 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −19,952 | 133,269 | D |
Loading xslF345X06/marketforms-73765.xml…